A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymia
Authors:
- R. ZanardiRZR. Zanardi
- E. SmeraldiESE. Smeraldi
- 1 May 2006
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 16 (4) , 281-287
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Randomized, Double-Blind, Placebo-Controlled Trial of Fluoxetine Treatment for Elderly Patients With Dysthymic DisorderThe American Journal of Geriatric Psychiatry, 2005
- Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group studyInternational Clinical Psychopharmacology, 2002
- Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group studyInternational Clinical Psychopharmacology, 2001
- Double-Blind Comparison of Sertraline, Imipramine, and Placebo in the Treatment of Dysthymia: Effects on PersonalityAmerican Journal of Psychiatry, 2000
- Venlafaxine in the Treatment of DysthymiaThe Journal of Clinical Psychiatry, 1999
- Amisulpride versus Amineptine and Placebo for the Treatment of DysthymiaNeuropsychobiology, 1999
- Dysthymic disorder: Treatment with mirtazapineDepression and Anxiety, 1999
- A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymiaAmerican Journal of Psychiatry, 1993
- 5‐HT2 receptor antagonism in dysthymic disorder: a double‐blind placebo‐controlled study with ritanserinActa Psychiatrica Scandinavica, 1991
- Dysthymic disorder: psychopathology of proposed chronic depressive subtypesAmerican Journal of Psychiatry, 1983